Sorrento Therapeutics (SRNE)

Sorrento Therapeutics (SRNE) Balance Sheet


Sorrento Therapeutics Balance Sheet

Sorrento Therapeutics's total assets for Q were $615.61M, a decrease of -2.61% from the previous quarter. SRNE total liabilities were $485.41M for the fiscal quarter, a -2.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Assets
$ 694.82M$ 535.82M$ 557.63M$ 624.09M$ 431.61M
Total Liabilities
$ 616.69M$ 395.09M$ 524.88M$ 416.59M$ 225.00M
Total Equity Gross Minority
$ 78.13M$ 140.73M$ 32.76M$ 207.50M$ 206.61M
Total Capitalization
$ 189.38M$ 257.41M$ 277.68M$ 432.61M$ 204.78M
Preferred Stock Equity
Capital Lease Obligations
$ 94.97M$ 53.93M$ 55.43M$ 0.00-
Currency in USD

Sorrento Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis